02/15
Headlines

ARQL

Why Need to Watch: ArQule Inc. (NASDAQ:ARQL), Texas Instruments Inc. (NASDAQ:TXN), Rhino Resource Partners LP (NYSE:RNO), United Technologies (NYSE:UTX), W.R. Berkley (NYSE:WRB)

Harvey Dyer03 mins

ArQule Inc. (NASDAQ:ARQL) announced that eight presentations of clinical and pre-clinical data on three early clinical-stage product candidates took place during the 26th EORTC-NCI-AACR Symposium held November 18-21, 2014 in Barcelona, Spain. ArQule Inc. (NASDAQ:ARQL) belongs to Healthcare sector. Its weekly performance is 6.25%. On last trading day company shares ended up $1.36. ArQule Inc….

Read More

Investors Are Watching : Time Warner Inc. (NYSE:TWX), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Allegheny Technologies Inc. (NYSE:ATI), ArQule Inc. (NASDAQ:ARQL), USMD Holdings, Inc. (NASDAQ:USMD)

John Bellich03 mins

Time Warner Inc. (NYSE:TWX) cut its ties to Time Inc., the once-great magazine publisher. The Tribune Company, keeping its television stations, has created a separately traded entity called Tribune Publishing for its newspapers. News Corp. now holds Rupert Murdoch’s newspapers, while 21st Century Fox has his entertainment properties. E. W. Scripps sent its papers packing….

Read More

New Lows: ArQule, Inc. (NASDAQ:ARQL), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Tetralogic Pharmaceuticals Corp (NASDAQ:TLOG), TrovaGene Inc (NASDAQ:TROV)

Mark Doerr03 mins

ArQule, Inc (NASDAQ:ARQL) CEO Paolo Pucci purchased 5,000 shares of the company’s stock in a transaction dated Tuesday, May 20th. The stock was purchased at an average cost of $1.42 per share, with a total value of $7,100.00. Following the transaction, the chief executive officer now directly owns 232,280 shares of the company’s stock, valued…

Read More

Biotech New Lows: ArQule (NASDAQ:ARQL), OvaScience Inc (NASDAQ:OVAS), Uniqure (NASDAQ:QURE), Egalet Corp (NASDAQ:EGLT)

Colin Pettis02 mins

ArQule Inc. (NASDAQ:ARQL) announced that the Company will present at the Needham 13th Annual Healthcare Conference. The presentation will be web cast and may be accessed through the investor relations section of the Company’s website http://www.arqule.com. ArQule, Inc. (NASDAQ:ARQL) stock performance was -2.92% in last session and finished the day at $1.66. Traded volume was…

Read More